If you're looking for funding to support your MPT research, see the opportunities here! Recently added opportunities are shown below.

The NICHDs' state-of-the art Biological Testing Facility supports female and/or male non-hormonal contraception development, including MPTs. This opportunity is to support the enablement of an IND/IDE study of a pre-clinical candidate that offers a safe, non-hormonal based therapy for female and/or male contraception that acts prior to fertilization and does not act via the hypothalamic-pituitary-gonadal axis. Apply by 15 January 2021.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is supporting and facilitating multidisciplinary approaches towards the development of new and/or improved contraceptive methods for women and men, including MPTs with non-hormonal contraceptive and anti-infective properties. This opportunity includes translational studies to facilitate the pre-clinical to clinical transition and increase the likelihood of clinical success, as well as behavioral and social research projects. Submit a Letter of Intent by 29 October 2021.

The IMPT launched a new webinar discussion series to address the priority action areas that we identified through our recent MPT fieldwide gap analyses and stimulate interest in the MPT field. In this series, we will cover an array of topics that will help advance the MPT field, including vaginal microbiome, sociobehavioral and market research, toxicity studies, and more. Look out for future webinar invites.

Watch our discussion on the role of the vaginal microbiome and MPTs with Dr. Jacques Ravel and Dr. Jennifer Deese.

Many of our IMPT partners will be attending HIVR4P, whose agenda includes multipurpose prevention technologies. Make sure to make room in your schedule to join the virtual symposiums and poster exhibitions on MPTs. Scan the program here!

28 January, 14:00 UTC, Channel 1 | More is better: Expanding the prevention pipeline

28 January, 15:00 UTC, Channel 1 | Multipurpose prevention technologies (MPTs) for prevention of HIV and pregnancy

4 February, 16:15 UTC, Channel 3 | One-stop shopping: Products, pathways and people

Track 6 | Median time to HIV testing and number of attempts to reach sexual contacts of HIV-positive index clients via assisted partner notification services in western Kenya

Track 8 | Multipurpose prevention technologies: Strategy recommendations to guide the most promising products from the lab to hands of women

IMPT Director, Bethany Young Holt, along with several IMPT partners, including from Daré Bioscience, Evofem Biosciences, Rhia Ventures, Male Contraceptive Initiative, YourChoice Therapeutics, Bill & Melinda Gates Foundation, and more will be participating to drive innovation, education, and investment in women’s reproductive health. See the summit agenda.

Evofem Biosciences provides update on pivotal phase 3 trial of EVO100 for prevention of chlamydia and gonorrhea. (December 17, 2020). Biospace.

IAVI announces launch of EDCTP-funded socio-behavioral project on accessible HIV prevention tools for African women. (December 3, 2020). IAVI.

Shot to prevent H.I.V. works better than daily pill in women. Mandavilli, A. (2020). The New York Times.

HIV prevention trials network awarded U.S. National Institutes of Health funding to continue research agenda. (2020). HPTN.

The PrEP pipeline. Johnson, M., Smith, R., & Badowski, M. (2020). Contagion Live.

Interview: Co-chair Sheena McCormack. Torri, T. (2020). HIVR4P.

We want to support your development into the next generation of reproductive health professionals, including MPT research. We’ve compiled some interesting reading and relevant resources as you explore career pathways in this field. Check it out!

The IMPT is the first and only initiative dedicated to advancing the field of multipurpose prevention technologies—products being designed to prevent a combination of HIV, other sexually transmitted infections (STIs), and/or unintended pregnancy. Your generous contribution today will help us in ensuring that women and families have the tools for a happy, healthy life. Donate today!